These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Buettner R; Mora LB; Jove R Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098 [TBL] [Abstract][Full Text] [Related]
3. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Silva CM Oncogene; 2004 Oct; 23(48):8017-23. PubMed ID: 15489919 [TBL] [Abstract][Full Text] [Related]
5. The epidermal growth factor receptor pathway: a model for targeted therapy. Scaltriti M; Baselga J Clin Cancer Res; 2006 Sep; 12(18):5268-72. PubMed ID: 17000658 [TBL] [Abstract][Full Text] [Related]
6. Roles of unphosphorylated STATs in signaling. Yang J; Stark GR Cell Res; 2008 Apr; 18(4):443-51. PubMed ID: 18364677 [TBL] [Abstract][Full Text] [Related]
7. Signaling through the epidermal growth factor receptor during the development of malignancy. Grandis JR; Sok JC Pharmacol Ther; 2004 Apr; 102(1):37-46. PubMed ID: 15056497 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of STAT signaling in inflammation and tumorigenesis. Adach A; Ellert-Miklaszewska A; Kaminska B Methods Mol Biol; 2009; 512():265-78. PubMed ID: 19347282 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations. Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092 [TBL] [Abstract][Full Text] [Related]
10. SFK-STAT pathway: an alternative and important way to malignancies. Hayakawa F; Naoe T Ann N Y Acad Sci; 2006 Nov; 1086():213-22. PubMed ID: 17185518 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer. Haura EB; Turkson J; Jove R Nat Clin Pract Oncol; 2005 Jun; 2(6):315-24. PubMed ID: 16264989 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257 [TBL] [Abstract][Full Text] [Related]
13. Interleukins and STAT signaling. Haque SJ; Sharma P Vitam Horm; 2006; 74():165-206. PubMed ID: 17027515 [TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance. Tencer L; Burgermeister E; Ebert MP; Liscovitch M Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034 [TBL] [Abstract][Full Text] [Related]
15. Signal Transducers and Activators of Transcription: Novel Targets for Anticancer Therapeutics. Bowman T; Yu H; Sebti S; Dalton W; Jove R Cancer Control; 1999 Oct; 6(5):427-435. PubMed ID: 10758575 [TBL] [Abstract][Full Text] [Related]
17. EGFR inhibitor-mediated apoptosis in solid tumors. Goel S; Hidalgo M; Perez-Soler R J Exp Ther Oncol; 2007; 6(4):305-20. PubMed ID: 18038764 [TBL] [Abstract][Full Text] [Related]
18. Structure, function, and regulation of STAT proteins. Lim CP; Cao X Mol Biosyst; 2006 Nov; 2(11):536-50. PubMed ID: 17216035 [TBL] [Abstract][Full Text] [Related]
19. The role of the EGFR signaling in tumor microenvironment. De Luca A; Carotenuto A; Rachiglio A; Gallo M; Maiello MR; Aldinucci D; Pinto A; Normanno N J Cell Physiol; 2008 Mar; 214(3):559-67. PubMed ID: 17894407 [TBL] [Abstract][Full Text] [Related]
20. Complex modulation of cell type-specific signaling in response to type I interferons. van Boxel-Dezaire AH; Rani MR; Stark GR Immunity; 2006 Sep; 25(3):361-72. PubMed ID: 16979568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]